期刊文献+

VEGF及其受体sFlt-1在子痫前期患者血清中的变化及意义 被引量:6

Changes and significance of serum VEGF and sFlt-1 in preeclampsia pregnant women
下载PDF
导出
摘要 目的探讨子痫前期患者血清中血管内皮生长因子(VEGF)及其可溶性血管内皮生长因子受体1(sFlt-1)的水平及意义。方法选择2011年8月至2012年3月子痫前期患者共60例(研究组),其中轻度子痫前期孕妇30例,重度子痫前期孕妇30例,以同期正常晚期妊娠孕妇30例作为对照组。采用酶联免疫吸附试验法测定两组患者血清VEGF及其sFlt-1水平。结果子痫前期组孕晚期及临产前VEGF水平显著低于正常对照组(t值分别为-160.762、22.690,均P<0.001),而sFlt-1水平显著高于正常对照组(t值分别为18.647、47.782,均P<0.001)。轻度子痫前期组孕晚期及临产前VEGF水平显著高于重度子痫前期组(t值分别为4.869、4.626,均P<0.05),而sFlt-1水平显著低于重度子痫前期组(t值分别为-3.59、-3.681,均P<0.05)。两组产后1周VEGF和sflt-1水平比较无显著性差异(t值分别为3.061、1.760,均P>0.05)。结论子痫前期患者血清中sFlt-1水平于孕晚期及临产前较正常孕妇明显增高,而VEGF水平降低,提示VEGF、sFlt-1可作为诊断子痫前期的指标之一。 Objective To investigate the serum levels and significance of vascular endothelial growth factor ( VEGF ) and its receptor soluble fms-like tyrosine kinase receptor 1 ( sFlt-1 ) in pregnant women with preeclampsia .Methods Totally 60 pregnant women with preeclampsia were selected in study group during the period of August 2011 to March 2012, including 30 cases with mild preeclampsia and 30 with severe preeclampsia .Another 30 normal women in late pregnancy were selected in control group .The levels of VEGF and sFlt-1 in two groups were detected by enzyme-linked immunosorbent assay (ELISA).Results The serum levels of VEGF in preeclampsia group at late pregnancy and postpartum were significantly lower than those in control group (t value was -160.762 and 22.690, respectively, both P〈0.001), but the serum levels of sFlt-1 were significantly higher than those in control group ( t value was 18.647 and 47.782, respectively, both P〈0.001).The serum levels of VEGF of mild preeclampsia group at late pregnancy and postpartum were significantly higher than those in severe preeclampsia group (t value was 4.869 and 4.626, respectively, both P〈0.05).However, the serum levels of sFlt-1 of mild preeclampsia group were significantly lower than those of severe preeclampsia group ( t value was -3.59 and -3.681, respectively, both P〈0.05).There was no significant difference in the levels of VEGF and sFlt-1 one week after delivery between two groups (t value was 3.061 and 1.760, respectively, both P〉0.05).Conclusion The level of sFlt-1 in serum of preeclampsia patients at late pregnant stage is significantly higher than normal pregnant women , whereas the VEGF level goes down .VEGF as well as sFlt-1 can be used as the indicators for diagnosing preeclampsia .
出处 《中国妇幼健康研究》 2014年第3期443-445,共3页 Chinese Journal of Woman and Child Health Research
关键词 子痫前期 血管内皮生长因子 可溶性血管内皮生长因子受体 变化 preeclampsia vascular endothelial growth factor (VEGF) soluble fms-like tyrosine kinase receptor 1 (sFlt-1) change
  • 相关文献

参考文献5

二级参考文献19

  • 1乐杰主编.妇产科学[M].第7版.北京:人民卫生出版社,2009.271-272.
  • 2Sibai B,Dekker G,Kupferminc M.Pre-eclampsia[J].Lancet,2005,365(9461):785-799.
  • 3Levine RJ,Maynard SE,Qian C,et al.Circulating angiogenic factors and the risk of preeclampsia[J].N Engl J Med,2004,350(7):672-683.
  • 4Chaiworapongsa T,Romero R,Kim YM,et al.Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia[J].J Matern Fetal Neonatal Med,2005,17(1):3-18.
  • 5Romero R,Nien JK,Espinoza J,et al.A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate[J].J Matern Fetal Neonatal Med,2008,21(1):9-23.
  • 6Moore Simas TA,Crawford SL,Solitro MJ,et al.Angiogenic factors for the prediction of preeclampsia in high-risk women[J].Am J Obstet Gynecol,2007,197(3):244.e1-244.e8.
  • 7Koga K,Osuga Y,Yoshino O,et al.Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia[J].J Clin Endocrinol Metab,2003,88(5):2348-2351.
  • 8Chaiworapongsa T,Romero R,Espinoza J,et al.Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia[J].Am J Obstet Gynecol,2004,190(6):1541-1547.
  • 9Shah D M.Preeclampsia:new insights[J].Curr Opin Nephrol Hypertens,2007,16(3):213-220.
  • 10Baumwell S,Karumanchi S A.Preeclampsia:clinical manifestations and molecular mechanisms[J].Nephron Clin Pract,2007,106(2):72-81.

共引文献17

同被引文献43

  • 1Veron D, Bertuccio C A, Marlier A, et al. Podocyte vascular endothelial growth factor (Vegf 164 ) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes[ J]. Diabetologia, 2011,54 (5) : 1227 - 1241.
  • 2Grundmann M, Haidar M, Placzko S, et al. Vitamin D im- proves the angiogenic properties of endothelial progenitor cells [ J ]. American Journal of Physiology-Cell Physiology, 2012, 303 (9) : C954 - C962.
  • 3McGuane J T, Danielson L A, Debrah J E, et al. Angiogenicgrowth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humans [ J ]. Hy- pertension, 2011, 57(6): 1151- 1160.
  • 4Shuman Moss L A, Jensen-Taubman S, Stetler-Stevenson W G. Matrix metalloproteinases: changing roles in tumor pro- gression and metastasis[J]. The American journal of patholo- gy, 2012, 181(6) : 1895 -1899.
  • 5Singh J, Ahmed A, Girardi G. Role of complement compo- nent C1 q in the onset of preeclampsia in mice[ J]. Hyperten- sion, 2011, 58(4) : 716 -724.
  • 6Luizon M R, Sandrim V C, Palei A C T, et al. Epistasis a- mong eNOS, MMP-9 and VEGF maternal genotypes in hyper- tensive disorders of pregnancy [ J ]. Hypertension Research, 2012, 35(9): 917-921.
  • 7Valdes G, Corthom J. Review : the angiogenic and vasodilato- ry utero-placental network[ J]. Placenta, 2011, 32 : S170 - S175.
  • 8常雅丽,李晓红,李萍,冯玉珍,刘静,陈灵芝.妊娠期高血压疾病患者胎盘组织中VEGF、MMP-9的表达及意义[J].中国妇幼保健,2010,25(23):3265-3267. 被引量:13
  • 9王海燕,杨海澜,马惠静,冯敏,索明莉.白血病抑制因子在子痫前期患者胎盘组织中的表达及意义[J].中国妇幼保健,2011,26(9):1399-1401. 被引量:4
  • 10颜建英,曾小燕,刘青闽.子痫前期孕妇血清、胎盘组织MMP-9及NGAL表达变化及其意义的研究[J].实用妇产科杂志,2011,27(6):464-467. 被引量:23

引证文献6

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部